India's Pharmaceutical Exports

Country Profile

Libya

Libya is an emerging destination for Indian pharmaceutical exports — $13.1M in FY 2025–26. Medicines accounts for 87% of shipments, with vaccines contributing $486K. The compound annual growth rate since FY2015 stands at 2.0%.

🇱🇾 $13.1M · 1.2× growth since FY2015 · 2.0% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$13.1M
Exports FY2025–26 DGCIS
1.2×
Growth FY2015→2026
2.0%
CAGR FY2015→2026
87%
Medicines Share
5
Product Categories Supplied
Libya is an emerging destination for Indian pharmaceutical exports — $13.1M in FY 2025–26. Medicines accounts for 87% of shipments, with vaccines contributing $486K. The compound annual growth rate since FY2015 stands at 2.0%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $11.4M (86.7%) Surgical & Hospital Supplies $1.01M (7.7%) Vaccines $486K (3.7%) Traditional & Herbal $155K (1.2%) Medicine Ingredients $98K (0.7%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Libya in the RBI overseas direct investment dataset (2011–2026).